National survey of extended-interval aminoglycoside dosing

Clinical Infectious Diseases

Volumn 30, Issue 3, 2000, Pages 433-439

  Chuck, Susan K ^a   Raber, Susan R ^c,d   Rodvold, Keith A ^a,b   Areff, Danyel ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ANTIBIOTIC THERAPY; ARTICLE; COST CONTROL; DOSE RESPONSE; DRUG EFFICACY; KIDNEY FUNCTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; INFANT; INFECTION; MIDDLE AGED; QUESTIONNAIRES; UNITED STATES;

EID: 0034034174     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313692     Document Type: Article

References (41)

1. 1. Erdman SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods. Part III: aminoglycoside antibiotics. Clin Pharmacokinet 1991;20:374-88.
2. 2. Lacy MK, Nicolau DP, Nightingale CH, Quintiliani R. The pharmacodynamics of aminoglycosides. Clin Infect Dis 1998;27:23-7.
3. 3. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997;39:677-86.
4. 4. Urban AW, Craig WA. Daily dosage of aminoglycoside. Curr Clin Top Infect Dis 1997;17:236-55.
5. 5. Galloe AM, Graudal N, Christensen HR, Kampmann JP. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur J Clin Pharmacol 1995;48:39-43.
6. 6. Munckhof WJ, Gayson ML, Turnidge JD. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 1996;37:645-63.
7. 7. Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996;124:717-25.
8. 8. Barza M, Ioannidis JP, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996;312:338-45.
9. 9. Ferriols-Lisart R, Alos-Alminana M. Effectiveness and safety of once-daily aminoglycoside: a meta-analysis. Am J Health Syst Pharm 1996;53: 1141-50.
10. 10. Freeman CD, Strayer AH. Mega-analysis of meta-analysis: an examination of meta-analysis with an emphasis on once-daily aminoglycoside comparative trials. Pharmacotherapy 1996;16:1093-102.
11. 11. Bailey TC, Little JR, Littenberg B, Reichley RM, Dunagan WC. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:786-95.
12. 12. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:796-809.
13. 13. Hatala R, Dinh TT, Cook DJ. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin Infect Dis 1997; 24:810-5.
14. 14. Gilbert DN. Meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides. Clin Infect Dis 1997;24:816-9.
15. 15. Belliveau PP, Nicolau DP, Nightingale CH. Quintiliani R. Once-daily gentamicin: experience in one hundred eighteen patients with postpartum endometritis. J Infect Dis Pharmacother 1995;1:11-8.
16. 16. Nicolau DP, Wu AH, Finocchiaro S, et al. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. Ther Drug Monit 1996;18:263-6.
17. 17. Parker SE, Davey PG. Once-daily aminoglycoside administration in gram-negative sepsis: economic and practical aspects. Pharmacoeconomics 1995;7:393-402.
18. 18. Marra F, Partovi N, Jewesson P. Aminoglycoside administration as a single daily dose: an improvement to current practice or a repeat of previous errors? Drugs 1996;52:344-70.
19. 19. Periti P. Pharmacoeconomic evaluation of once-daily aminoglycoside treatment. J Chemother 1995;7:380-94.
20. 20. Mithani H, Brown G. The economic impact of once-daily versus conventional administration of gentamicin and tobramycin. Pharmacoeconomics 1996;10:494-503.
21. 21. Hitt CM, Klepser ME, Nightingale CH, Quintiliani R, Nicolau DP. Pharmacoeconomic impact of once-daily aminoglycoside administration. Pharmacotherapy 1997;17:810-4.
22. 22. Thureen PJ, Reiter PD, Gresores A, Stolpman NM, Kawato K, Hall DM. Once-versus twice-daily gentamicin dosing in neonates ≥34 weeks' gestation: cost-effectiveness analyses. Pediatrics 1999;103:594-8.
23. 23. Schumock GT, Raber SR, Crawford SY, Naderer OJ, Rodvold KA. National survey of once-daily dosing of aminoglycoside antibiotics. Pharmacotherapy 1995;15:201-9.
24. 24. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agents Chemother 1995;39: 650-5.
25. 25. Gilbert DN, Lee BL, Dworkin RJ, et al. A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med 1998;105:182-91.
26. 26. Gilbert DN, Moellering RC, Sande MA, eds. Sanford guide to antimicrobial therapy. 28th ed. Vienna, Virginia: Antimicrobial Therapy, 1998:117.
27. 27. Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 1996;40:2494-9.
28. 28. Barclay ML, Duffull SB, Begg EJ, Buttimore RC. Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve. Aust N Z J Med 1995;25:230-5.
29. 29. Barclay ML, Kirkpatrick CMJ, Begg EJ. Once daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored? Clin Pharmacokinet 1999;36:89-98.
30. 30. Koo J, Tight R, Rajkumar V, Hawa Z. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Am J Med 1996;101:177-83.
31. 31. Paterson DL, Robson JMB, Wagener MM. Risk factors of toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 1998;13: 735-9.
32. 32. Rodvold KA, Danziger LH, Quinn JP. Single daily doses of aminoglycosides. Lancet 1997;350:1412.
33. 33. Bertino JS Jr, Rotschafer JC. Single daily dosing of aminoglycoside: a concept whose time has not yet come. Clin Infect Dis 1997;24:820-3.
34. 34. American Hospital Association Guide. 1997-98 ed. Chicago: American Hospital Association, 1997.
35. 35. US Department of Commerce, Bureau of the Census. 1990 census of population: general population characteristics of the United States. Washington, DC: US Government Printing Office, 1992.
36. 36. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-89. National Nosocomial Infections Surveillance System. Am J Med 1991;91(Suppl 3B):86S-9S.
37. 37. Anaizi N. Once-daily dosing of aminoglycosides: a consensus document. Int J Clin Pharmacol Ther 1997;35:223-6.
38. 38. Strausbaugh LJ. IDSA Emerging Infections Network preliminary report for urgent query on gentamicin adverse reactions. Alexandria, VA: Infectious Diseases Society of America, 20 October 1998.
39. 39. Gin AS, Ariano R, Zelenitsky S, Durcharme M, Rodvold KA, Zhanel GA. The practice of once-daily aminoglycoside dosing in Canada: a national survey. Can J Hosp Pharm 1999;52:12-7.
40. 40. Peterson J. More Illinois institutions use once-daily aminoglycoside dosing. KeePosted [newsletter of Illinois Council of Health-System Pharmacists] 1996;21:4.
41. 41. Hsu J, Ellington TM, Lai L, Hardigan P, Robinson M. Current use of high-dose aminoglycosides in the hospitals throughout the United States. In: Proceedings of the American Health-System Pharmacists Midyear Clinical Meeting. 1997;32:133E.